Dr. Kunwar Shailubhai, Ph.D., M.B.A., has been Chief Executive Officer of Rasna Therapeutics, Inc. since April 14, 2017. Dr. Shailubhai is the Founder of Synergy Pharmaceuticals Inc., and has been its Chief Scientific Officer since July 9, 2008 and Executive Vice President since November 21, 2015. Dr. Shailubhai served as the Senior Vice President of Drug Discovery at Synergy Pharmaceuticals Inc. from March April 6, 2004 to July 2008. He served as Head of Research and Development at Callisto Pharmaceuticals, Inc. (Formerly, Webtronics Inc.) and also served its Executive Vice President of Research and Development from May 2003 to March 2004 and Executive Vice President. From 2001 to April 2003, Dr. Shailubhai served as the Vice President for Drug Discovery of Synergy Pharmaceuticals Inc., where he was chiefly responsible for the preclinical development of GC-C agonist program for drugs to treat colon cancer and GI inflammation. He served as Chief Scientific Officer of Pawfect Foods Inc. since July 2008. From 1993 to 2000, he served at Monsanto Life Sciences Company as Group Leader of the Cancer Chemoprevention Group and was involved in several cancer research projects. He serves as a Director of Rasna Therapeutics, Inc. Dr. Shailubhai has been a Non-Executive Director at Tiziana Life Sciences PLC since January 22, 2015. He has 17 issued patents, several pending patent applications and 40 research publications in journals of international repute. He previously served as a Senior Staff Fellow at the National Institutes of Health and as an Assistant Professor at the University of Maryland. Dr. Shailubhai holds Ph.D. in Microbiology in 1984 from the University of Baroda, India and an M.B.A. in 2001 from the University of Missouri, St. Louis.
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.
